0.952
price down icon4.80%   -0.048
after-market  After Hours:  .9599  0.0079   +0.83%
loading

Why is Assertio Holdings Inc (ASRT) Stock down?

We've noticed a 8.57% decline in Assertio Holdings Inc (ASRT) stock during the 2024-05-10 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
09 Nov, 2023:

Assertio Therapeutics Stock (ASRT) dropped by 43.19% from $2.13 to $1.21 in the trading on Thursday November 9, 2023. The reason why ASRT stock down today is due to the worse-than-expected third-quarter financial results. It is due to the loss of Indocin exclusivity and Rolvedon results below expectations driving significant charges to our net income

  • Adjusted earnings per share of 1 cent. That’s well below the 10 cents per share that Wall Street was expecting. It’s also a major drop from the 22 cents per share reported in Q3 2022.
  • Revenue of $35.1 million, compare to the $50.43 million that analysts were predicting. However, it is a slight increase over the company’s revenue of $34.3 million in the same period of the year prior.
$66.54
price up icon 1.40%
$17.40
price up icon 1.52%
$53.58
price down icon 0.78%
drug_manufacturers_specialty_generic RDY
$70.53
price down icon 0.58%
$10.31
price down icon 0.77%
$134.62
price down icon 4.17%
Cap:     |  Volume (24h):